The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. BIOLASE Inc.’s current trading price is -99.42% away from its 52-week high, while its distance from the 52-week low is -31.80%. The stock’s price range for this period has been between $2.94 and $346.99 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.07 million for the day, a number notably higher than the average daily volume of 0.23 million over the last three months.
BIOLASE Inc. (BIOL) stock is currently valued at $2.01. During the last session, the stock experienced a remarkable rise, reaching $3.57 after opening at $3.50. The stock briefly dropped to $3.2223 before ultimately closing at $3.26.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
BIOLASE Inc. ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $346.99 on 09/15/22, while the lowest value for the same period was recorded at $2.94 on 09/14/23.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
BIOLASE Inc. (BIOL) has experienced a quarterly decline of -72.31% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.03M and boasts a workforce of 188 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 9.79, with a change in price of -21.04. Similarly, BIOLASE Inc. recorded 175,419 in trading volume during the last 100 days, posting a change of -91.48%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for BIOL stands at 2.12. Similarly, the long-term debt-to-equity ratio is also 1.80.
BIOL Stock Stochastic Average
As of today, BIOLASE Inc.’s raw stochastic average for the last 50 days stands at 2.57%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 5.16%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 10.12% and 13.59%, respectively.
BIOL Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Until today this year the stock’s price performance recorded a decrease of -96.92%. However, over the last six months, the performance has been stronger by -94.86%. The price of BIOL decreased -67.40% over the last 30 days. And in the last five days, it has fallen by -36.55%.
